Last reviewed · How we verify
NCT03981354
Nutritional Status and Its Modifications After Hip Replacement
trial in Hip Arthropathy in 60 participants. Completed in 1 June 2022.
1 June 2022
Quick facts
| Lead sponsor | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 31 May 2019 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 June 2022 |
| Sites | 1 location across Italy |
Conditions studied
- Hip Arthropathy — all drugs for Hip Arthropathy →
- Malnutrition; Anemia — all drugs for Malnutrition; Anemia →
- Frail Elderly Syndrome — all drugs for Frail Elderly Syndrome →
Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — full company profile →
Who can join
Adults 60 to 85, any sex, with Hip Arthropathy or Malnutrition; Anemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Data literature lacks of evidence concerning the variation of the nutritional status in patients undergoing hip surgery, thus preventing an effective application a nutritional support program. It is therefore necessary to start identifying the clinical steps (pre-operative and post-operative) that may be defined as critical control points for malnutrition. The observation should foresee the identification of nutritional status indicators, such as weight, hemoglobin, albumin, food intake, and others that might affect a proper recovery. This study aims to investigate the prognostic nutritional factors that might influence clinical outcomes, and their variation in relation to hospitalization and rehabilitation periods.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
How Do Older Patients with End-Stage Osteoarthritis of the Hip Eat Prior to Hip Replacement? A Preliminary Snapshot That Highlights a Poor Diet.
Briguglio M, Sirtori P, Mangiavini L, Buzzi S, et al · · 2023 · cited 2× · PMID 38068726 · DOI 10.3390/nu15234868 -
Influence of Preoperative Diagnosis of Nutritional Disorders on Short-Term Outcomes After Hip Arthroplasty: A Cohort Study of Older Adults.
Briguglio M, Latella M, Sirtori P, Mangiavini L, et al · · 2025 · PMID 40732944 · DOI 10.3390/nu17142319
Verify or expand the search:
- PubMed search for NCT03981354
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hip Arthropathy
Currently open trials in the same condition.
- NCT07023094 — PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery · Phase 4 · recruiting
- NCT06017128 — Sexual Counseling's Impact on Hip Replacement Patients' Sexual Function and Quality of Life: a PLISSIT Model Study · NA · active not recruiting
- NCT06603831 — Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology · NA · recruiting
- NCT06317870 — Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty · NA · recruiting
- NCT06432543 — Polyethylene Wear Particle Analysis of THA · recruiting
Other I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials
Trials by the same sponsor.
- NCT07386405 — Validation and Cultural Adaptation of the KOOS-ACL Scale for the Italian Population · not yet recruiting
- NCT07352111 — High-risk Coronary Atherosclerosis in Subjects With Family History of Myocardial Infarction · NA · recruiting
- NCT07304323 — Prepare II - Predictive Model Training and External Validation · recruiting
- NCT07337499 — Comparison of Maglumi X3 SNIBE With Other Analytical Methods in Laboratory Medicine for 25-(OH)D Quantification · recruiting
- NCT06940245 — Use of Virtual Reality for the Assessment of Attentional and Reaction Abilities for Fall Risk Evaluation · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03981354 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
- Last refreshed: 11 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03981354.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing